Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| APS | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 407.0 | Evidence | |||||
| APS | CSK | CSK: Tyrosine-protein kinase CSK | 268.0 | Evidence | |||||
| APS | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 268.0 | Evidence |
|
||||
| APS | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 200.0 | Evidence |
|
||||
| APS | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 198.0 | Evidence |
|
||||
| APS | LYN | LYN: Tyrosine-protein kinase Lyn | 180.0 | Evidence |
|
||||
| APS | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 176.0 | Evidence | |||||
| APS | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 162.0 | Evidence | |||||
| APS | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 161.0 | Evidence | |||||
| APS | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 149.0 | Evidence | |||||
| APS | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 149.0 | Evidence | |||||
| APS | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 137.0 | Evidence | |||||
| APS | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 134.0 | Evidence | |||||
| APS | KIT | KIT: Mast/stem cell growth factor receptor precursor | 132.0 | Evidence |
|
||||
| APS | SYK | SYK: Tyrosine-protein kinase SYK | 128.0 | Evidence |
|
||||
| APS | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 119.0 | Evidence | |||||
| APS | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 106.0 | Evidence | |||||
| APS | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| APS | BMX | N/A | 88.80 | Evidence | |||||
| APS | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 88.80 | Evidence | |||||
| APS | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 88.80 | Evidence | |||||
| APS | INSR | INSR: Insulin receptor precursor | 80.00 | Evidence |
|
||||
| APS | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 80.00 | Evidence | |||||
| APS | HCK | N/A | 79.50 | Evidence | |||||
| APS | JAK1 | 79.50 | Evidence |
|
|||||
| APS | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 79.40 | Evidence | |||||
| APS | EPHB3 | EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor | 73.60 | Evidence | |||||
| APS | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 52.80 | Evidence | |||||
| APS | NCK2 | NCK2: Cytoplasmic protein NCK2 | 39.10 | Evidence | |||||
| APS | CRKL | CRKL: Crk-like protein | 31.20 | Evidence | |||||
| APS | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 25.90 | Evidence | |||||
| APS | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 25.3 | Evidence | |||||
| APS | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 25.3 | Evidence | |||||
| APS | CD79A | CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain | 24.90 | Evidence | |||||
| APS | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 22.80 | Evidence | |||||
| APS | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 22.30 | Evidence | |||||
| APS | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 20.50 | Evidence | |||||
| APS | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 20.50 | Evidence |
|
||||
| APS | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 20.50 | Evidence | |||||
| APS | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 20.40 | Evidence | |||||
| APS | STAT3 | 19.70 | Evidence | ||||||
| APS | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 18.90 | Evidence | |||||
| APS | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 17.30 | Evidence | |||||
| APS | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 16.20 | Evidence | |||||
| APS | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 15.50 | Evidence | |||||
| APS | VAV1 | VAV1, VAV: Proto-oncogene vav | 15.50 | Evidence | |||||
| APS | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 15.50 | Evidence | |||||
| APS | STAM2 | STAM2: Signal transducing adapter molecule 2 | 15.30 | Evidence | |||||
| APS | LNK | SH2B3, LNK: SH2B adapter protein 3 | 15.00 | Evidence | |||||
| APS | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 15.00 | Evidence | |||||
| APS | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 13.80 | Evidence | |||||
| APS | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 13.50 | Evidence | |||||
| APS | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 13.40 | Evidence | |||||
| APS | DOK1 | DOK1: Docking protein 1 | 12.40 | Evidence | |||||
| APS | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 12.40 | Evidence | |||||
| APS | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 11.40 | Evidence | |||||
| APS | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 11.40 | Evidence | |||||
| APS | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 11.20 | Evidence | |||||
| APS | IRS1 | IRS1: Insulin receptor substrate 1 | 11.20 | Evidence | |||||
| APS | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 10.70 | Evidence | |||||
| APS | SOS1 | SOS1: Son of sevenless homolog 1 | 10.70 | Evidence | |||||
| APS | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 10.10 | Evidence |
|
||||
| APS | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 10.00 | Evidence | |||||
| APS | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 10.00 | Evidence | |||||
| APS | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 9.92 | Evidence | |||||
| APS | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 9.92 | Evidence | |||||
| APS | IRS2 | IRS2: Insulin receptor substrate 2 | 9.89 | Evidence | |||||
| APS | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 9.14 | Evidence | |||||
| APS | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 9.14 | Evidence | |||||
| APS | CTTN | CTTN, EMS1: Src substrate cortactin | 8.92 | Evidence | |||||
| APS | CREBBP | CREBBP, CBP: CREB-binding protein | 8.00 | Evidence | |||||
| APS | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 7.85 | Evidence | |||||
| APS | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 7.59 | Evidence | |||||
| APS | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 7.40 | Evidence | |||||
| APS | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 6.78 | Evidence | |||||
| APS | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 6.52 | Evidence | |||||
| APS | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 6.52 | Evidence | |||||
| APS | ITGB4 | N/A | 6.52 | Evidence | |||||
| APS | GRAP | GRAP: GRB2-related adapter protein | 6.31 | Evidence | |||||
| APS | EPOR | EPOR: Erythropoietin receptor precursor | 5.88 | Evidence |
|
||||
| APS | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 5.50 | Evidence | |||||
| APS | DAPP1 | N/A | 4.73 | Evidence | |||||
| APS | DNM1 | DNM1, DNM: Dynamin-1 | 4.68 | Evidence | |||||
| APS | GRB10 | N/A | 4.68 | Evidence | |||||
| APS | KIRREL | KIRREL, KIRREL1, NEPH1: Kin of IRRE-like protein 1 precursor | 4.68 | Evidence | |||||
| APS | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 4.31 | Evidence | |||||
| APS | CD19 | N/A | 4.06 | Evidence | |||||
| APS | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.93 | Evidence | |||||
| APS | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 3.49 | Evidence | |||||
| APS | CASP3 | CASP3, CPP32: Caspase-3 precursor | 2.63 | Evidence | |||||
| APS | ANKK1 | ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein | 2.43 | Evidence | |||||
| APS | SCAP2 | SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 | 2.24 | Evidence | |||||
| APS | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 2.24 | Evidence | |||||
| APS | CAMK2G | Calcium/calmodulin-dependent protein kinase isoform A (Fragment) | 2.24 | Evidence | |||||
| APS | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 2.13 | Evidence | |||||
| APS | EVL | N/A | 2.10 | Evidence | |||||
| APS | PSEN1 | PSEN1, AD3, PS1, PSNL1: Presenilin-1 | 1.78 | Evidence | |||||
| APS | APC | N/A | 1.70 | Evidence | |||||
| APS | SH3BP5 | N/A | 1.70 | Evidence | |||||
| APS | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 1.64 | Evidence | |||||
| APS | SOCS2 | SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 | 1.43 | Evidence | |||||
| APS | FCER1G | FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor | 1.42 | Evidence | |||||
| APS | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.30 | Evidence | |||||
| APS | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
| APS | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
| APS | CAV1 | CAV1, CAV: Caveolin-1 | 1.06 | Evidence | |||||
| APS | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 1.04 | Evidence |
|
||||